FDA — authorised 21 December 2018
- Marketing authorisation holder: ALEXION PHARM
- Status: approved
FDA authorised Ultomiris on 21 December 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 21 December 2018.
ALEXION PHARM holds the US marketing authorisation.